Search Results 391-400 of 11732 for Drug-resistant TB
A Study To Assess The Effectiveness And Safety Of UGN-102 As A Primary Chemoablation Agent In Patients With Low Grade Non-Muscle-Invasive Bladder Cancer (LG ...
... treatment. The safety of the study drug combination will also be studied. Participation eligibility. Participant eligibility includes age, gender, type and ...
It is used in patients who have received treatment with other medicines. This medicine is to be given only by or under the supervision of your doctor. This ...
... Tuberculosis, Sexually transmitted... disease, Infection, Cellulitis, Lyme disease, Multidrug-resistant ... of unknown origin, Bacteremia. Show more areas of ...
Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease ... Research. Researchers identify new kidney pathway with help ...
Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came ...
Multiple trials are examining alternatives to fecal microbiota transplantation, including capsule- and enema-based therapies, for treatment of recurrent ...
The main focus of this study is to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had a liver transplant.
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.